For decades, millions of Americans have taken armfuls of blood pressure medication and still watched their numbers refuse to fall — a quiet, grinding failure that medicine has struggled to explain. A sweeping new study now suggests that for more than a quarter of these patients, the true culprit was never the heart or the arteries, but a hormone: cortisol, the body's ancient stress messenger, running unchecked and silently undermining every treatment offered. The MOMENTUM study, spanning fifty medical centers and over a thousand patients, invites medicine to reckon with what it has long been t
ScienceDaily
· Mar 26, 2026
· health
· 2 min de leitura
High
Apuração: Verificado
Study finds elevated cortisol in 27% of resistant hypertension patients
Nearly 10 million Americans with resistant hypertension face elevated cardiovascular risk including heart attacks and heart failure, potentially affecting millions more if underlying hypercortisolism remains undiagnosed.
◉
Science & Space
6989 artigos relacionados
NASA Launches Artemis II: Four Astronauts Head to Moon in Historic Mis…
Devdiscourse · 100% correspondência
NASA study finds Earth microbes could survive on Moon's South Pole, co…
Texas Public Radio | TPR · 99% correspondência
Blue Origin Probed Over Rocket Failure as Mars Rover Finds Organic Com…
Devdiscourse · 99% correspondência
Israeli radiation vest shows promise for safer deep-space missions
jns.org · 99% correspondência
Starship's Raw Power Masks Mars Challenge: Orbital Refueling Still Unp…
Space Daily · 99% correspondência
Cobertura Relacionada
Science Daily · Aug 24
Trump to Honor Artemis II Astronauts With Congressional Space Medal
President Trump will award the Congressional Space Medal of Honor to the Artemis II crew for completing a historic 10-da…
News-Medical · Aug 24 Decade-long Scottish study finds screen time's effects on child development far more complex than fearedA Scottish longitudinal study tracking 3,786 children from ages 5-15 found screen use showed limited and inconsistent as…
Education News Canada · Aug 24 UNB researchers help confirm first evidence of elemental sulfur on MarsUniversity of New Brunswick researchers contributed to the first confirmed discovery of elemental sulfur on Mars, sugges…
South China Morning Post · Aug 24 Chinese researchers develop compact X-ray camera for real-time medical imaging with lower radiationA Chinese research team has created a tabletop X-ray camera that captures dynamic medical imaging with lower radiation d…
Viés e Enquadramento
⚖
ScienceDaily presents a medical research finding with straightforward reporting, minimal loaded language, and appropriate scientific framing without apparent ideological bias.
Bias Direction
center
Confidence
HIGH
Problem-solution framing emphasizing medical discovery and clinical significance. The article frames elevated cortisol as a 'hidden' cause and 'opening new treatment pathways,' positioning the research as clinically meaningful progress.
hard-to-treat
hidden hormonal cause
struggle to control
serious health problems
opening new treatment pathways
Perspective from patients with resistant hypertension on treatment experiences
Cost or accessibility considerations for new potential treatments
Limitations or caveats about the 27% finding (e.g., causation vs. correlation)
Viewpoint from endocrinologists on clinical implementation challenges
Discussion of why this connection wasn't identified earlier
Impacto Geopolítico
🌎
This is a medical research article about cortisol and hypertension with no geopolitical implications.
Escalation Risk
low
Confidence
HIGH
Lente Econômica
📈
Study identifies elevated cortisol in 27% of resistant hypertension patients, potentially opening new treatment pathways and reducing cardiovascular complications in ~10M affected Americans.
Market Signal
bullish
Confidence
HIGH
Pharmaceutical and biotechnology
Healthcare services and diagnostics
Medical devices and testing
Health insurance
Patients with resistant hypertension gain new diagnostic options and potential treatment alternatives, potentially reducing out-of-pocket costs from failed medication regimens and preventing costly cardiovascular events. Improved treatment efficacy could reduce hospitalizations and emergency care expenses.
FDA may accelerate approval pathways for cortisol-targeting therapies; Medicare/Medicaid may expand coverage for dexamethasone suppression testing; clinical guidelines will likely be updated to include hypercortisolism screening in resistant hypertension protocols, affecting reimbursement structures.